Call for the Standing Independent Evaluation Committee for HT’s National Facilities
The public notice for the pre-selection of experts with proven professional qualifications for the subsequent constitution – by appointment of the Supervisory Board of HT – of the Standing Independent Evaluation Committee (CIVP), for the evaluation of applications for access to the National Facilities implemented at the Foundation, was published today by the Ministries of University and Research and of Health.
Through the procedure, which will close on 2 September 2023, expressions of interest will be collected from distinguished scientists working in the following fields:
- Functional and population genomics
- Transcriptomics
- Structural biology
- Cancer biology and evolution
- Light microscopy and image analysis
- Computational biology
- Epidemiology
- Single-cell omics
- Epigenomics
- Genome engineering and stem cell biology
Applications can only be submitted using the platform: Human Technopole Notice – GEA (mur.gov.it)
For further information: https://www.mur.gov.it/it/news/martedi-04072023/call-esperti-commissione-valutazione-piattaforme-nazionali-presso-human
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.